Kyntra Bio, Inc. (KYNB) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Kyntra Bio, Inc. (KYNB) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $28.4M, listed on NASDAQ, employing roughly 225 people, carrying a beta of 1.04 to the broader market. Kyntra Bio, Inc. Led by Thane Wettig, public since 2014-11-14.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for KYNB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →